Explore what ACTEMRA has to offer:

Please see Important Safety Information below.

*MTX dose was initiated at 7.5 mg/week and increased to a maximum dose of 20 mg/week within 8 weeks. The recommended starting dose for ACTEMRA IV is 4 mg/kg every 4 weeks followed by an increase to 8 mg/kg every 4 weeks based on clinical response.

ACTEMRA is not indicated for the treatment of MTX-naïve patients with RA. ACTEMRA is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more DMARDs.

ACR=American College of Rheumatology; DMARD=disease-modifying antirheumatic drug; DMARD-IR=inadequate response to DMARDs; MTX=methotrexate.

IV Dosing Calculator

Calculate the appropriate ACTEMRA dose for your patient’s weight.

Accessibility for Patients

Genentech provides patients support to help them access the ACTEMRA they are prescribed.

Contact a Rep

Connect with a Genentech clinical specialist to learn more about ACTEMRA.